Skip to the page

Data / Form D filings / CARGO Therapeutics, Inc.

CARGO Therapeutics, Inc.: Form D filing

CARGO Therapeutics, Inc., a biotechnology company in San Mateo, CA, filed a Form D with the SEC in 2023. The latest, on March 1, 2023, reports $68.8 million sold of a $200.8 million offering to 19 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1900 ALAMEDA DE LAS PULGAS SUITE 350, San Mateo, CA, 94403
Phone
(650) 379-6143
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2019
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1966494

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 1, 2023New notice$200,760,000$68,832,003$131,927,99719Feb 9, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Gina ChapmanExecutive Officer, Director
Abraham BassanDirector
Cassandra Gianna LucaDirector
Jeffrey WalshDirector
Krishnan ViswanadhanDirector
Crystal MackallDirector
Heath LukatchDirector
John OrwinDirector
Anup RadhakrishnanExecutive Officer

Other biotechnology companies in California that filed recently

Every Form D from the week of Feb 27, 2023 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what CARGO Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.